G545-0332 Screening compound: 3-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]amino}-N-[(4-methylphenyl)methyl]-4-(pyrrolidin-1-yl)benzamide

G545-0332 Screening compound: 3-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]amino}-N-[(4-methylphenyl)methyl]-4-(pyrrolidin-1-yl)benzamide
G545-0332 Screening compound: 3-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]amino}-N-[(4-methylphenyl)methyl]-4-(pyrrolidin-1-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G545-0332
3-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]amino}-N-[(4-methylphenyl)methyl]-4-(pyrrolidin-1-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G545-0332

Molecular Formula

C28H30N4O4 (C28 H30 N4 O4)

Compound Name

3-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]amino}-N-[(4-methylphenyl)methyl]-4-(pyrrolidin-1-yl)benzamide

IUPAC name

3-{[(23-dihydro-14-benzodioxin-6-yl)carbamoyl]amino}-N-[(4-methylphenyl)methyl]-4-(pyrrolidin-1-yl)benzamide

SMILES

Cc1ccc(CNC(c(cc2)cc(NC(Nc(cc3)cc4c3OCCO4)=O)c2N2CCCC2)=O)cc1

InChI

InChI=1S/C28H30N4O4/c1-19-4-6-20(7-5-19)18-29-27(33)21-8-10-24(32-12-2-3-13-32)23(16-21)31-28(34)30-22-9-11-25-26(17-22)36-15-14-35-25/h4-11,16-17H,2-3,12-15,18H2,1H3,(H,29,33)(H2,30,31,34)

InChI Key

INGRQSAQILBRGA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15018723

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

486.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.388

Distribution Coefficient, logD

4.388

Water Solubility, LogSw

-4.31

Polar Surface Area

75.598

Acid Dissociation Constant (pKa)

10.70

Base Dissociation Constant (pKb)

8.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

G545-0332 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
  • Nervous system
  • Cardiovascular
Targets:
  • Others
  • Ion Channels

References: we are preparing a list of scientific research reports with G545-0332 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G545-0332?
Check Price and Availability of G545-0332, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G545-0332 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G545-0332
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G545-0332
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G545-0332 available by request